Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2017 1
2021 2
2022 4
2023 3
2024 1
2025 1
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean belimumabs pregnancy registry (1 results)?
Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry.
Juliao P, Wurst K, Pimenta JM, Gemzoe K, Landy H, Moody MA, Tilson H, Covington D, Moore T, Marino R, Gilbride J, Liu A, Meizlik P, Petri M. Juliao P, et al. Birth Defects Res. 2023 Jan 15;115(2):188-204. doi: 10.1002/bdr2.2091. Epub 2022 Sep 30. Birth Defects Res. 2023. PMID: 36177676 Free PMC article.
The Belimumab Pregnancy Registry (BPR, GSK Study BEL114256; NCT01532310) was created to evaluate pregnancy and infant outcomes following belimumab exposure. ...There was no indication or pattern of birth defects associated with belimumab. …
The Belimumab Pregnancy Registry (BPR, GSK Study BEL114256; NCT01532310) was created to evaluate pregnancy and i …
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation.
Götestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N, Dolhain R, Förger F, Khamashta M, Ruiz-Irastorza G, Zink A, Vencovsky J, Cutolo M, Caeyers N, Zumbühl C, Østensen M. Götestam Skorpen C, et al. Ann Rheum Dis. 2016 May;75(5):795-810. doi: 10.1136/annrheumdis-2015-208840. Epub 2016 Feb 17. Ann Rheum Dis. 2016. PMID: 26888948 Free article.
A European League Against Rheumatism (EULAR) task force was established to define points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Based on a systematic literature review and pregnancy exposure data from s …
A European League Against Rheumatism (EULAR) task force was established to define points to consider on use of antirheumatic drugs before …
Considering belimumab during pregnancy: A more viable option over time.
Vela-Casasempere P, Caño Alameda R, Gómez Sabater S, Cortell Aznar S, Pérez Pascual E. Vela-Casasempere P, et al. Lupus. 2024 Jun;33(7):700-715. doi: 10.1177/09612033241245549. Epub 2024 Apr 9. Lupus. 2024. PMID: 38594808 Free PMC article. Review.
Studies were evaluated and visualised descriptively. RESULTS: Sixteen pregnancies of 12 lupus women were included, six (involving eight pregnancies) received belimumab throughout their illness, five of them during some period of gestation. ...After the search …
Studies were evaluated and visualised descriptively. RESULTS: Sixteen pregnancies of 12 lupus women were included, six (involving eig …
Belimumab use during pregnancy: a summary of birth defects and pregnancy loss from belimumab clinical trials, a pregnancy registry and postmarketing reports.
Petri M, Landy H, Clowse MEB, Gemzoe K, Khamashta M, Kurtinecz M, Levy RA, Liu A, Marino R, Meizlik P, Pimenta JM, Sumner K, Tilson H, Connolly MB, Wurst K, Harris J, Quasny H, Juliao P, Roth DA. Petri M, et al. Ann Rheum Dis. 2023 Feb;82(2):217-225. doi: 10.1136/ard-2022-222505. Epub 2022 Oct 5. Ann Rheum Dis. 2023. PMID: 36198440 Free PMC article.
OBJECTIVE: Describe available data on birth defects and pregnancy loss in women with systemic lupus erythematosus (SLE) exposed to belimumab. METHODS: Data collected from belimumab clinical trials, the Belimumab Pregnancy Registry (BPR), …
OBJECTIVE: Describe available data on birth defects and pregnancy loss in women with systemic lupus erythematosus (SLE) exposed to …
Guideline for the diagnosis, treatment and long-term management of cutaneous lupus erythematosus.
Lu Q, Long H, Chow S, Hidayat S, Danarti R, Listiawan Y, Deng D, Guo Q, Fang H, Tao J, Zhao M, Xiang L, Che N, Li F, Zhao H, Lau CS, Ip FC, Ho KM, Paliza AC, Vicheth C, Godse K, Cho S, Seow CS, Miyachi Y, Khang TH, Ungpakorn R, Galadari H, Shah R, Yang K, Zhou Y, Selmi C, Sawalha AH, Zhang X, Chen Y, Lin CS. Lu Q, et al. J Autoimmun. 2021 Sep;123:102707. doi: 10.1016/j.jaut.2021.102707. Epub 2021 Aug 5. J Autoimmun. 2021. PMID: 34364171
To provide all dermatologists and rheumatologists with a practical guideline for the diagnosis, treatment and long-term management of CLE, this evidence- and consensus-based guideline was developed following the checklist established by the international Reporting Items for Pract …
To provide all dermatologists and rheumatologists with a practical guideline for the diagnosis, treatment and long-term management of CLE, t …
Use of belimumab throughout pregnancy to treat active systemic lupus erythematosus: a case report.
Danve A, Perry L, Deodhar A. Danve A, et al. Semin Arthritis Rheum. 2014 Oct;44(2):195-7. doi: 10.1016/j.semarthrit.2014.05.006. Epub 2014 Jun 6. Semin Arthritis Rheum. 2014. PMID: 25005336 Review.
After detailed discussions, she was treated with belimumab, which controlled her SLE and allowed withdrawal of mycophenolate. Belimumab was continued throughout the pregnancy, leading to well-controlled SLE and uneventful course, albeit with the presence of m …
After detailed discussions, she was treated with belimumab, which controlled her SLE and allowed withdrawal of mycophenolate. Beli …
10 Years of belimumab experience: What have we learnt?
Levy RA, Gonzalez-Rivera T, Khamashta M, Fox NL, Jones-Leone A, Rubin B, Burriss SW, Gairy K, Maurik AV, Roth DA. Levy RA, et al. Lupus. 2021 Oct;30(11):1705-1721. doi: 10.1177/09612033211028653. Epub 2021 Jul 8. Lupus. 2021. PMID: 34238087 Free PMC article. Review.
Belimumab was then approved for use in children in Europe, the USA and Japan in 2019, and China and Brazil in 2020. ...Ongoing clinical studies are evaluating belimumab's effectiveness in various indications beyond SLE. Post-marketing and registry studies are …
Belimumab was then approved for use in children in Europe, the USA and Japan in 2019, and China and Brazil in 2020. ...Ongoing clinic …
Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
Erton ZB, Sevim E, de Jesús GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D; APS ACTION. Erton ZB, et al. Lupus Sci Med. 2022 Jun;9(1):e000633. doi: 10.1136/lupus-2021-000633. Lupus Sci Med. 2022. PMID: 35701043 Free PMC article.
The primary objective was to describe the characteristics of patients with and without aPL-related composite outcomes based on their first observed pregnancies following registry recruitment. RESULTS: Of the 55 first pregnancies observed after registry …
The primary objective was to describe the characteristics of patients with and without aPL-related composite outcomes based on their first o …
Lessons From COVID-19 for Pandemic Preparedness: Proceedings From a Multistakeholder Think Tank.
Narayanasamy S, Curtis LH, Hernandez AF, Woods CW, Moody MA, Sulkowski M, Turbett SE, Baden LR, Gulick RM, Pau AK, Adam SJ, Marks P, Stockbridge NL, Dobbins JR, Krofah E, Leav B, Pang P, Roessig L, Vedin O, Waldstreicher J, Berman SC, Cremisi H, Schofield L, Gandhi RT, Naggie S. Narayanasamy S, et al. Clin Infect Dis. 2023 Dec 15;77(12):1635-1643. doi: 10.1093/cid/ciad418. Clin Infect Dis. 2023. PMID: 37435958 Free PMC article.
Epidemiological perspectives on SLE and APS in MENA: Burden, barriers, and a path toward improved outcomes.
Namas R, Al Qassimi S, Almarzooqi A. Namas R, et al. Lupus. 2026 Feb;35(2):208-217. doi: 10.1177/09612033251408525. Epub 2025 Dec 19. Lupus. 2026. PMID: 41419792 Review.
APS adds an additional layer of complexity through thrombotic events and pregnancy complications. Purpose: This review brings together current knowledge on the epidemiology, clinical patterns, and management challenges of SLE and APS across the region. ...Recent advances, …
APS adds an additional layer of complexity through thrombotic events and pregnancy complications. Purpose: This review brings togethe …
12 results